Navigation Links
Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial
Date:12/30/2008

Women who took beta carotene or vitamin C or E or a combination of the supplements had a similar risk of cancer as women who did not take the supplements, according to data from a randomized controlled trial in the December 30 online issue of the Journal of the National Cancer Institute.

Epidemiological studies have suggested that people whose diets are high in fruits and vegetables, and thus antioxidants, may have a lower risk of cancer. Results from randomized trials that address the issue, however, have been inconsistent and have rarely supported that observation.

In the current study, Jennifer Lin, Ph.D., of the Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues tested the impact of antioxidant supplements on cancer incidence in a randomized controlled trial. A total of 7,627 women who were at high risk of cardiovascular disease were randomly assigned to take vitamin C, vitamin E, or beta-carotene.

With an average of 9.4 years of follow-up time, there was no statistically significant benefit from antioxidant use compared with placebo in terms of disease risk or mortality due to cancer. Overall, 624 women developed cancer and 176 died from cancer during the follow-up time. Compared with placebo, the relative risk of a new cancer diagnosis was 1.11 for women who took vitamin C, 0.93 for women who took vitamin E, and 1.00 for women who took beta carotene. None of these relative risks was statistically significantly different from 1.

"Supplementation with vitamin C, vitamin E, or beta carotene offers no overall benefits in the primary prevention of total cancer incidence or cancer mortality," the authors conclude. "In our trial, neither duration of treatment nor combination of the three antioxidant supplements had effects on overall fatal or nonfatal cancer events. Thus, our results are in agreement with a recent review of randomized trials indicating that total mortality was not affecte
'/>"/>

Contact: Caroline McNeil
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Calcium and vitamin D may not be the only protection against bone loss
2. A novel target for therapeutics against Staph infection
3. Researchers recreate SARS virus, open door for potential defenses against future strains
4. In the war against diseases, nerve cells need their armor
5. A new weapon in the fight against obesity and diabetes
6. Global methane levels on the rise again
7. Severe gestational hypertension may protect against testicular cancer
8. Methane gas levels begin to increase again
9. Gene against bacterial attack unravelled
10. Purple tomatoes: The richness of antioxidants against tumors
11. Research identifies type of vaccine that holds promise in protecting against TB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
(Date:12/3/2009)PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal
Breaking Biology News(10 mins):How to read brain activity? 2Papillomavirus silences innate immune response 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2MDS Inc and Danaher Corporation Receive Second Request for Information from U S Federal Trade Commission for MDS Analytical Technologies Sale 60598 1MDS Inc and Danaher Corporation Receive Second Request for Information from U S Federal Trade Commission for MDS Analytical Technologies Sale 60598 2VisualSonics Appoints New President and CEO 60594 1VisualSonics Appoints New President and CEO 60594 2Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 1Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 2Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 3Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference 5947 4
...rus, an emerging public health concern in Africa a...most feared of exotic pathogens. , Due to its vir...s are available, scientists studying the agent hav...ent protocols, limiting research to a few highly s...tists to develop countermeasures. , Now, however,...
...Exeter has highlighted the problems of reintroduci...Published online in the journal Biological Conserv...tes of captive carnivores that are released into t...e captive-born carnivores survives in the wild, wi...ent high-profile conservation projects have involv...
...have pinpointed a set of common variations in huma... who carry them. Some of these variations are more...help future studies examining whether lupus is mor..., according to a new study. , Also, the findings ...rch for cutting-edge lupus treatments, according t...
Other Biology News:Ebola virus disarmed by excising a single gene 2Ebola virus disarmed by excising a single gene 3Captive carnivores not up to wild living 2DNA variations signal lupus risk 2DNA variations signal lupus risk 3
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/1/2009)INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...Madison, Wis. - Perscitus Biosciences, a Madison ...n from the Wisconsin Department of Commerce . , ...lop and commercialize two technologies based on re...chairman of Perscitus Biosciences, said the Commer...e researchers to further develop its technologies ...
...Editor,s note : This is the first in a four-part ... the discovery process in a lawsuit and, in partic...mation, or ESI. In Part I, attorney Tim Hansen of ...hlight the rule changes, while subsequent articles...l. , , Recently, the Federal Rules of Civil Proc...
... The tech industry buzzed last week over what many...d Bill Gates on the stage of the Wall Street Jo...l. While some might have wanted fireworks, the two...rd I have not often used to describe Jobs). , ,As ...ion in the most mutually complimentary terms (you ...
Other Biology Technology:Quick peeks, Clawback Agreements, and the rules of electronic discovery 2Quick peeks, Clawback Agreements, and the rules of electronic discovery 3What if Jobs and Gates had teamed up? 2What if Jobs and Gates had teamed up? 3What if Jobs and Gates had teamed up? 4
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone 1.F.1 from Abcam
Rabbit Anti-L Kynurenine Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-P5 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: